Literature DB >> 7062059

Measurement of cerebral glucose utilization using washout after carotid injection in the rat.

W H Oldendorf, W M Pardridge, L D Braun, P D Crane.   

Abstract

The carotid injection technique, used previously to quantitate the kinetics of blood-brain barrier transport of metabolic substrates, may be modified to analyze the rate of cerebral glucose utilization. A 0.2-ml solution of [14C]glucose (GF) and [3H]methylglucose (M), an internal reference, is rapidly injected into the carotid artery, followed by microwave fixation of brain at various times up to 4 min after injection. The brain radioactivity is separated into a fraction containing neutral hexoses (GF and M) and a fraction containing metabolites of glucose. The GF/M ratio is related to the rate constant (k3) of brain glucose utilization by the simple, linear equation: 1n(GF/M) = ln(GF0/0)--k3t, where GF0/M0 = the brain uptake index of glucose, relative to methylglucose, at 5--15 s after injection, and t = the time after carotid injection, e.g., 1--4 min. It is assumed that (a) the rate of influx due to recirculation of label is minimal during the 4-min circulation period; and (b) the rate constants of glucose efflux (k2) and methylglucose efflux (k2*) are identical. Independent estimates of k2 and k2* showed these parameters to be identical: k2 = 0.14 +/- 0.08 min-1; k2* = 0.14 +/- 0.02 min-1. A logarithmic plot of GF/M ratios versus time was linear (r = 0.99), and was described by the slope k3 = 0.21 +/- 0.02 min-1. Assuming glucose is uniformly distributed in brain, then the glycolytic rate = k3 x brain glucose = (0.21 min-1) (2.6 mumol g-1) = 0.55 mumol min-1 g-1 for the cortex of the barbiturate-anesthetized rat. These studies provide the basis for a simple method of measurement of regional brain glycolysis that does not require either the use of correction factors, e.g., the lumped constant, or the use of differentially labeled glucose.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7062059     DOI: 10.1111/j.1471-4159.1982.tb07920.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  5 in total

1.  The effect of pretreatment with pentobarbital on the extent of [14C] incorporation from [U-14C]glucose into various rat brain glycolytic intermediates: relevance to regulation at hexokinase and phosphofructokinase.

Authors:  L P Miller; S Mayer; L D Braun; P Geiger; W H Oldendorf
Journal:  Neurochem Res       Date:  1988-04       Impact factor: 3.996

2.  Tracer kinetic model of blood-brain barrier transport of plasma protein-bound ligands. Empiric testing of the free hormone hypothesis.

Authors:  W M Pardridge; E M Landaw
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

3.  Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study.

Authors:  C L Farrell; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

Review 4.  In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition.

Authors:  Yukiko Murata; Sibylle Neuhoff; Amin Rostami-Hodjegan; Hiroyuki Takita; Zubida M Al-Majdoub; Kayode Ogungbenro
Journal:  AAPS J       Date:  2022-01-13       Impact factor: 4.009

5.  Transport of propranolol and lidocaine through the rat blood-brain barrier. Primary role of globulin-bound drug.

Authors:  W M Pardridge; R Sakiyama; G Fierer
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.